Arcticzymes Technologies ASA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway. Show More...
-
Website https://arcticzymes.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.38 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share NOK -1.18 -0.69 -0.85 -0.6 -0.52 -0.39 -0.46 -0.56 -0.3 -0.12 0.27 Dividends NOK Payout Ratio % * Shares Mil 24.0 30.0 30.0 39.0 43.0 45.0 45.0 45.0 46.0 48.0 49.0 Book Value Per Share * EUR 0.32 0.23 0.13 0.14 0.26 0.22 0.19 0.12 0.11 0.1 0.11 Free Cash Flow Per Share * EUR -0.45 -0.04 -0.14 -0.07 -0.06 -0.04 -0.04 -0.06 -0.06 -0.010 Return on Assets % -35.42 -31.77 -54.84 -53.22 -26.67 -16.35 -21.91 -33.81 -21.57 -8.77 15.0 Financial Leverage (Average) 1.9 1.28 1.56 1.29 1.13 1.17 1.27 1.4 1.28 1.72 1.57 Return on Equity % -58.52 -49.46 -74.95 -73.35 -31.39 -18.78 -26.64 -44.69 -28.81 -13.01 23.83 Return on Invested Capital % -58.52 -52.17 -77.44 -75.71 -33.61 -19.97 -27.42 -44.89 -29.36 -9.28 18.3 Interest Coverage -37.66 -34.69 -6.44 Current Ratio 1.79 4.17 1.96 3.78 8.19 6.41 4.35 2.96 3.96 3.19 3.75 Quick Ratio 1.7 3.9 1.17 3.28 7.49 5.89 3.92 2.55 3.16 2.25 3.3 Debt/Equity 0.28 0.24